Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To determine whether the presenilin 1 (PS1), presenilin 2 (PS2) and amyloid beta-protein precursor (APP) mutations linked to familial Alzheimer's disease (FAD) increase the extracellular concentration of amyloid beta-protein (A beta) ending at A beta 42(43) in vivo, we performed a blinded comparison of plasma A beta levels in carriers of these mutations and controls. A beta 1-42(43) was elevated in plasma from subjects with FAD-linked PS1 (P < 0.0001), PS2N1411 (P = 0.009), APPK670N,M671L (P < 0.0001), and APPV7171 (one subject) mutations. A beta ending at A beta 42(43) was also significantly elevated in fibroblast media from subjects with PS1 (P < 0.0001) or PS2 (P = 0.03) mutations. These findings indicate that the FAD-linked mutations may all cause Alzhelmer's disease by increasing the extracellular concentration of A beta 42(43), thereby fostering cerebral deposition of this highly amyloidogenic peptide.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [11]
In the citing paper
“Similar to PSEN1 , PSEN2 mutations may also cause increased production of long A 𝛃 peptide species (481, 523), although this needs more investigation.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [523]
In the citing paper
“It is well established that this mutation causes concomitant increases in secreted A42 and A40 (Cai et al., 1993;Citron et al., 1994;Scheuner et al., 1996).”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Scheuner et al., 1996
In the citing paper
“In a previous study of human plasma (Scheuner et al., 1996), we showed that the Swedish APP K670N,M671L mutation increases both A42 and A40 and that other FAD-linked APP, PS1, and PS2 mutations selectively increase A42.”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Scheuner et al., 1996
In the citing paper
“In that report, we suggested that cerebral A deposition in FAD occurs because of an increase in CNS A that develops as part of a generalized genetic effect that also increases plasma A.”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Scheuner et al., 1996
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Self-citationCloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Self-citationCandidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Self-citationJarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Self-citationJarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCitron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Self-citationIsolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Self-citation
Cited by
Items 2,401–2,500 of 2,576
Characterisation and treatment of hereditary and acquired systemic amyloidosis
Gillmore, J. D. (2001) · OpenGrey (Institut de l'Information Scientifique et Technique)
Immunotherapy Against Amyloid-β Protofibrils: Opportunities and Challenges
Lannfelt, L. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3560-4_4
Self-citationNEUROBIOLOGIA DA DOENÇA DE ALZHEIMER
Stella, F. (2013)
Dorey, E. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6258
The Search for Biomarkers in Alzheimer's Disease
Meiliana, A., & Wijaya, A. (2010) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v2i1.107 · Cited by 3
The Interaction Between Gamma-Secretase And Its Inhibitors And Modulators – Structural Insights
Gertsik, N. (2016) · eCommons (Cornell University) · Cited by 1
The role of phosphatidylinositol 3-kinases in autophagy regulation
Devereaux, K. A. (2014) · doi:10.7916/d8qz2842
Interaction studies of luminescent conjugated oligothiophenes with aggregated Amyloid β
Sandberg, A. (2013) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Carter, A. B. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Hormonal and non-hormonal factors associated with cognition in post-menopausal women
Rodrigues, M. A. (2004) · UWA Profiles and Research Repository (UWA)
The microrna-mediated regulation of proteins implicated in the pathogenesis of Alzheimer's Disease
Chopra, N. (2016) · IUScholarWorks (Indiana University) · doi:10.7912/c28019
Alpha-synuclein expression influences the processing of the amyloid precursor protein
Hall‐Roberts, H. (2016) · The University of Bath Online Publications Store (The University of Bath)
Physiological role of amyloid precursor protein during neural development
Banote, R. K. (2017) · Gothenburg University Publications Electronic Archive (Gothenburg University)
TRAFFICKING OF ALPHA SECRETASE ADAM10: NEW INSIGHTS INTO THE MOLECULAR MECHANISM OF MODULATION
Saraceno, C. (2012) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/saraceno-claudia_phd2012-02-08
“enhance the processing of APP to form A (Scheuner et al., 1996), the amyloid hypothesis has”
BackgroundMasters, C. L., & Beyreuther, K. T. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_1 · Cited by 2
Tirniceriu, A. (2009) · DuEPublico (University of Duisburg-Essen)
Neurochemical Aspects of β-Amyloid Cascade Hypothesis for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00001-x · Cited by 1
Dhar, D. (2013) · TSpace (University of Toronto)
Phillips, E. C. (2017) · Research Portal (King's College London)
Metaplasticity Tunes Functional Plasticity in the Rodent Hippocampus
Li, Q. (2015) · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)) · doi:10.24355/dbbs.084-201503260942-0
Amyloid Fibril Toxicity Still Unresolved
Clapp-Lilly, K. L., & Duffy, L. K. (2000) · Journal of Alzheimer s Disease · doi:10.3233/jad-2000-2213
Assessing Cognition In A Mouse Model Of Alzheimer’s Disease
Mels, J. (2018) · Scholarship@Western (Western University) · Cited by 1
AXL receptor tyrosine kinase regulates Apolipoprotein E expression
Zhao, W. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0372324
Alternation of Mitochondrial and Golgi Apparatus in Neurodegenerative Disorders
Sharma, S., Kaur, P., Gupta, S., & Sharma, S. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch005
Mondadori, C. (2006) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-163345
Conformational Regulation of Cell Surface Receptor Proteolysis
Hayward, A. N. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
Amyloid beta and tau proteins in Alzheimer’s disease and Down syndrome
Mehta, P. D. (2018) · CRC Press eBooks · doi:10.1201/9781315376875-4
A study of the global effects of Apolipoprotein E using lipidomics
Hawksworth, J. I. (2019) · ORCA Online Research @Cardiff (Cardiff University)
Papel dos canais iônicos na Doença de Alzheimer
Holanda, M. M. D. A., Segundo, L. M. D. B. M., de Medeiros, I. A., & da Silva, B. A. (2019) · Revista Neurociências · doi:10.34024/rnc.2009.v17.8574
Recombinant AAV Gene Therapy and Delivery
Carty, N. (2009) · Digital Commons - University of South Florida (University of South Florida)
Tanninen, S. E. (2018) · TSpace (University of Toronto) · Cited by 1
Zhu, S. (2011) · Mspace (University of Manitoba)
Genomics of Alzheimer’s disease
Rosenberg, R. N., Lambracht‐Washington, D., Yu, G., & Xia, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00001-1
From brain to muscle and back : novel approaches to harness the benefits of exercise
Kelahmetoglu, Y. (2020) · Figshare
A Young Man with Memory and Walking Difficulties
Shin, M., Chamoun, M., Pascoal, T. A., Savard, M., Soucy, J., Guiot, M. C., Rosa‐Neto, P., & Gauthier, S. G. (2021) · Cambridge University Press eBooks · doi:10.1017/9781316941294.004
Synthesis of the His 6-Tagged Recombinant Protein APPC99-His and His-PS1 Using RTS 500
Murayama, M., Sun, X., & Takashima, A. (2002) · Springer eBooks · doi:10.1007/978-3-642-59379-6_24
Sandrock, A. W. (2021) · Annals of Neurology · doi:10.1002/ana.26254
Яхьяевич, Я. Н., & Vagabov, N. M. (2009) · VESTNIK OF ASTRAKHAN STATE TECHNICAL UNIVERSITY SERIES MARINE ENGINEERING AND TECHNOLOGIES · Cited by 1
Amyloid beta resistance and the Warburg effect: Re-examining Alzheimer's disease
Newington, J. T. (2013) · Scholarship@Western (Western University)
Search for early TTR-related biomarkers in a transgenic AD mouse model
Santos, L. M. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/h957-t073 · Cited by 1
Turner, R. S. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch25
Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_4
Modeling Autism Spectrum Disorders Using Human Neurons
Muotri, A. R. (2013) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-36648-2_10
Presenilin/γ-Secretase in the Pathogenesis of Alzheimer’s Disease
Tomita, T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_20
Organische psychische Störungen
Kurz, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-48554-4_164
Swerdlow, R. H., Anderson, H. S., & Burns, J. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-56782-2_290-2
Sandbrink, R. (1998) · Springer eBooks · doi:10.1007/978-3-642-72074-1_8
Swerdlow, R. H., Anderson, H. S., & Burns, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-57111-9_290
γ-Secretase as a Target for Alzheimer's Disease
Wolfe, M. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_8
Gillespie, N. A., Rissman, R. A., Elman, J. A., McKenzie, R. E., Tu, X. M., Xian, H., Reynolds, C. A., Panizzon, M. S., Lyons, M. J., Eglit, G. M. L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.09.503234
Aspartic Proteases of Alzheimer's Disease: β- and γ--Secretases
Wolfe, M. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.10077-x
Ridha, B. H., & Yousry, T. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4160-5009-4.50053-4
Eccles, M. K., Groth, D. M., Verdile, G., & Agostino, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.17.541079
Targeting Various Pathogenic Pathways for the Development of Anti-alzheimer’s Drugs: An Update
Ambreen, S., Fatima, N., Umar, M., Shaququzzaman, M., Alam, M. M., & Ali, R. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266274924231002110733
Hanotte, J. L. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/161150
Recent progress in the pathology, diagnosis, and treatment of Alzheimer’s disease
Yu, X. (2023) · Theoretical and Natural Science · doi:10.54254/2753-8818/21/20230827
Hemodiyaliz Hastalarında Kateter İlişkili Enfeksiyon Etkenleri
Kaya, H. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1668
Menstrüel Siklusun Evrelerinin Uyku, İştah ve Vücut Ağırlığı Üzerine Etkileri
Özüpek, G., & Altay, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1671
Metabolik Hastalıklarda Asprosinin Rolü
Akçılar, R. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1669
Metisilin Dirençli Staphylococcus aureus (MRSA)
Sağlam, M., Kılıç, İ. H., & Zer, Y. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1677
Fahrioğlu, S. L., Yılmaz, İ., & İlgi, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1675
İyonlaştırıcı Olmayan Radyasyonun Yaşamımızdaki Yeri
Yavaş, M. C. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1673
Amiloid Beta Peptidler: in-vitro Alzheimer Hastalığı Toksisite Modellerinde Kullanımları
Kurt, S., & Çam, F. S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1678
Dalak Anatomisi ve Klinik Önemi
Erbek, E., & BOLATLI, G. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1674
Gebelikte Parasetamol (Asetaminofen) Kullanımı Güvenli mi?
Şen, F. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1676
Köse, H. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1670
Coşar, A. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1672 · Cited by 1
Sağlık Bilimleri Araştırmaları: Temel Tıp- IV
Kaya, H., Ibrahim Halil GAZIANTEP UNIVERSITY KILIC, Akçılar, R., Köse, H., Özüpek, G., Altay, İ. S., Coşar, A., Yavaş, M. C., Erbek, E., BOLATLI, G., et al. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384
Yerel bir virüsten Yeni Bir Epidemiye mi? Maymun Çiçeği Virüsü (Monkeypox) Virüsü Yapısı
Bozlak, Ç. E. B. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1681
Salmonella spp. Enfeksiyonları
Gümüşburun, S. A., Demirdöğen, Y., Vural, U., Boyraz, E. F., & Eslami, M. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1679
Effects of Radiofrequency Radiations on the Male Reproductive System
Yavaş, M. C. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1680
Gorgij, F., Nouri, H., & Ghahghaei, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4157212/v1
An Automatic Method to Extract Patent Citations from Google
Kousha, K., & Thelwall, M. A. (2015) · Figshare · doi:10.6084/m9.figshare.1418234
Fong, V., Kanuri, B., Traubert, O. D., Lui, M., & Patel, S. B. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02214-6
“While rare genetic early-onset forms of AD are associated with the over-production of abnormal proteins, including Aß and tau (Scheuner et al. 1996; Naj et al. 2017), the more common late-onset Alzheimer’s disease is associated with reduced clearance of Aß from the brain (Mawuenyega et al. 2010;…”
BackgroundTwo major culprits: Amyloidogenic Aβ and non-amyloidogenic tau
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00010-3
Human genetics: Establishment of cause-and-effect relationships
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00013-9
Nakamura, R., Matsuda, A., Higashi, Y., Hayashi, Y., Konishi, M., Saito, M., & Akizawa, T. (2024) · Biomolecules · doi:10.3390/biom14101234 · Cited by 2
Genomics of Alzheimer’s disease
Rosenberg, R. N., Lambracht‐Washington, D., Yu, G., & Xia, W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00035-2
A Brief Review on Caenorhabditis elegans Role in Modelling Neurodegenerative Disease
Vig, H., Shukla, P., Mishra, A., Pal, A., & Wal, A. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249340567241004043542
Luo, S., Xu, X., Liu, J., Tang, B., Zhang, J. Z. H., & Duan, L. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126562
Ikezu, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_22
Microglial glutathione and glutamate: regulation mechanisms
Fry, V. A. H. (2009) · UCL Discovery (University College London) · Cited by 1
Skin Biomarkers of Neurodegenerative Diseases
Reilly-Jankowiak, L., Bargar, C., Bunn, D., & Chen, S. G. (2025) · Springer eBooks · doi:10.1007/978-3-031-66513-4_6
Qi, W., Long, Y., Li, Z., Zhao, Z., Shi, J., Xie, W., Wang, L., Tan, Y., Zhou, T., Liang, M., et al. (2025) · eLife · doi:10.7554/elife.99462.2
The amyloid cascade hypothesis
Castellani, R. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-99651-8.00003-x
Advancements in Research on Retinal Biomarkers in Vascular Cognitive Impairment
张, 玲. (2025) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2025.43381
Amyloid β Deposition, Tau Phosphorylation, ApoE4 Dysfunction, and Formaldehyde
Lü, J., & He, R. (2025) · Springer eBooks · doi:10.1007/978-981-96-7281-3_10
Phenotypic variability in early-onset dementia segregating with a novel APP (p.I718M) variant
Johansson, C., Rodriguez‐Vieitez, E., Blūma, M., Nennesmo, I., Thonberg, H., Ullgren, A., Jelić, V., Zetterberg, H., Blennow, K., Nordberg, A. K., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01890-9
Chromosome Missegregation in Alzheimer's Disease Caused by Presenilin 1
Boeras, D. I. (2005) · Digital Commons - University of South Florida (University of South Florida)
Stem Cell Therapy for Neurological Disorders: From Bench to Bedside
Barbuti, P. A. (2014) · Springer eBooks · doi:10.1007/978-81-322-2110-4_4
“Mutations in PSEN1 and PSEN2 have been found to impair the activity of ”-secretase that is involved in the cleavage of APP, which also results in an increased A“42 to A“40 ratio [6–9].”
BackgroundPresenilin 2 — APP Interactions
Wasco, W., Tanzi, R. E., Moir, R. D., Crowley, A. C., Merriam, D. E., Romano, D., Jondro, P. D., & Kellerman, B. A. (1998) · Springer eBooks · doi:10.1007/978-3-642-72103-8_7
Self-citationMetabolomics in Alzheimer's disease
Zubair, M. (2013) · Research Explorer (The University of Manchester)
A study of the role of presenilin (1) in regulating synaptic function at hippocampal synapses
Yu, L. M. Y. (2010) · UCL Discovery (University College London)
Johansson, C., Þórðardóttir, S., Laffita-Mesa, J., Pannee, J., Rodriguez‐Vieitez, E., Zetterberg, H., Blennow, K., & Graff, C. (2024) · Figshare · doi:10.6084/m9.figshare.27107560
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612336
Metadata
- Authors
- Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, L., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., & Younkin, S.
- Affiliations
- Case Western Reserve University (US)
- Mayo Clinic (US)
- Karolinska Institutet (SE)
- Brigham and Women's Hospital (US)
- Takeda (Japan) (JP)
- University of Washington (US)
- University of South Florida (US)
- Harvard University (US)
- ORCID
- Venue
- Nature Medicine
- Published
- 1996-08
- Volume
- 2
- Issue
- 8
- Pages
- 864-870
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2101077392
- Semantic Scholar
- ce2164647cb7fb8dcec21d95359a92ec9830047a
- Cited by
- 2,599
- References
- 40
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 58 · 2023: 74 · 2022: 45 · 2021: 66 · 2020: 66 · 2019: 58 · 2018: 53 · 2017: 64 · 2016: 76 · 2015: 72 · 2014: 77 · 2013: 91 · 2012: 96
- FWCI
- 102.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, familial Alzheimer's disease, presenilin 1, presenilin 2, amyloid precursor protein, APP mutations, amyloid plaques
- MeSH terms
- Alzheimer Disease, Cells, Cultured, Female, Fibroblasts, Humans, Male, Membrane Proteins, Mutation, Peptide Fragments, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Culture Media, Conditioned, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.